Anti-TNF-refractory inflammatory bowel disease associated with a novel XIAP frameshift variant successfully treated with ustekinumab.

Stelara (ustekinumab) - J&J

http://www.ncbi.nlm.nih.gov/pubmed/42771130

Hidetaka Eguchi; Hiromichi Shoji; Keisuke Jimbo; Natsuki Ito; Takahiro Kudo; Toshiaki Shimizu; Yasushi Okazaki

Sep 23, 2026